• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1009544-28
Device Problems Inflation Problem (1310); Difficult to Remove (1528); Improper or Incorrect Procedure or Method (2017); Failure to Advance (2524)
Patient Problems Stroke/CVA (1770); Renal Failure (2041)
Event Date 04/23/2014
Event Type  Injury  
Event Description
It was reported that the procedure was to treat a lesion in the tortuous right coronary artery (rca).A 2.25x28mm xience nano stent delivery system (sds) was successfully advanced and the stent was successfully deployed in the proximal lesion.A second 2.25x28mm xience nano sds was dipped in saline prior to use and negative prep was performed inside the patient's anatomy.During advancement through the deployed stent to treat the distal lesion, the stent implants became caught.The second xience nano sds could not be advanced or removed.The guiding catheter was deep-seated in an attempt to disengage the two stents; however, this was unsuccessful.An attempt was made to deploy the stent in its current position; however, the device failed to inflate and a balloon leak was noted.Although force was applied, further attempts to withdraw the device were unsuccessful.The guiding catheter was removed and the sheath was changed from a 6-french to an 8-french.All devices were then removed as a single unit, and the procedure was stopped.There was a clinically significant delay in the procedure.Reportedly, the patient experienced a stroke and was transferred to the intensive care unit (icu).The patient remains hospitalized in renal failure.The distal lesion was never treated.It is unknown what, if any treatment was provided for the stroke or renal failure.No additional information was provided.
 
Manufacturer Narrative
(b)(4): against resistance, incorrect prep, distal to stent.The additional xience nano device referenced is being filed under a separate medwatch report.It is indicated that the device is not returning for evaluation; therefore a failure analysis of the complaint device could not be completed.The reported patient effects of cerebrovascular accident (stroke) and renal failure are known observed and potential patient effects as listed in the xience v and xience nano everolimus eluting coronary stent system electronic instructions for use.A review of the lot history record revealed no non-conformances that would have contributed to the reported event.A query/review of the complaint history of the reported lot did not indicate a manufacturing issue.Based on the reviewed information, no product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key3809187
MDR Text Key18921793
Report Number2024168-2014-03064
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P070015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 04/25/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/13/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/06/2015
Device Catalogue Number1009544-28
Device Lot Number2121841
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/25/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
STENT: 2.25X28MM XIENCE NANO
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age69 YR
-
-